Immunotherapy Monitoring
The development of methods to propagate immune T-cells, and in particular tumor specific T-cells from the patients with cancer, lead to an important breakthrough; the identification of MAGE-1,a melanoma-specific antigen that stimulates human T-cells in-vitro. With antigen specific T-cells as a reagents, it was possible to clone the MAGE-1 studies showed that the human immune system can respond tumor antigens, and the findings stimulated a productive effort to discover tumor antigens. The result is a long and still-growing list of antigens from a variety of tumor that could serve a variety of tumor’s that could serve as targets for treatment.
Related Conference of Immunotherapy Monitoring
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
Immunotherapy Monitoring Conference Speakers
Recommended Sessions
- Cancer Vaccines
- Immune Checkpoint inhibitors
- Pediatric Oncology Diagnosis
- Tumor markers and drug targeting
- Antibody Therapy of Cancer
- Brain Tumors
- Cancer Biomarkers
- Cancer Clinical Trials
- Cancer Immunology & Immunotherapy
- Cancer Micro and Immuno environment
- Cancer Research and Prevention
- Combining Cancer Immunotherapies
- COVID 19 effect on Cancer Patients
- Drug Discovery and Development in Cancer Research
- Engineered T-Cell Therapy
- Immuno-Oncology studies
- Immunotherapy Monitoring
- Multiple Myeloma
- Novel Approaches in Cancer & Tumor
- Oncology Nursing and Care
- Organ-Defined Cancers
- Pediatric Cancer Surgery
- Pediatric Oncology
- Pediatrics Drug Toxicity
- Psychology in Children with Cancer
- Radiology and Imaging in Cancer
- Radiology in Pediatric Oncology
- Tumor biology and Carcinogenesis
- Tumor Immunogenicity
- Tumor Immunology and Immunotherapy
- Tumor immunotherapy research
- Tumors
Related Journals
Are you interested in
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)